You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Litigation Details for The California Institute of Technology v. Broadcom Limited (C.D. Cal. 2016)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in The California Institute of Technology v. Broadcom Limited
The small molecule drug covered by the patent cited in this case is ⤷  Get Started Free .

Litigation Summary and Analysis for The California Institute of Technology v. Broadcom Limited | 2:16-cv-03714

Last updated: August 15, 2025

Introduction

The case of The California Institute of Technology (Caltech) v. Broadcom Limited, filed in the U.S. District Court for the Central District of California, stands as a significant legal dispute centered on patent infringement allegations. This litigation highlights complex issues of intellectual property rights, innovation, and corporate patent strategy within the semiconductor and technology sectors. The outcome and legal strategies involved offer critical insights into patent enforcement, licensing negotiations, and the impact on emerging and established tech companies.

Background and Parties Involved

The California Institute of Technology (Caltech), a renowned research university specializing in science and engineering, holds multiple patents related to microelectronics and semiconductor technologies developed through extensive research. These patents are regarded as vital intellectual assets contributing to Caltech’s licensing revenues and technological influence.

Broadcom Limited, a global technology leader primarily engaged in semiconductor and infrastructure software solutions, became embroiled in patent litigation after allegedly utilizing Caltech's patented technologies without licensing agreements. Broadcom's acquisition of multiple chipsets and infrastructure products prompted Caltech to pursue legal action for patent infringement, asserting ownership rights over critical innovations in semiconductor manufacturing.

Legal Claims and Allegations

Caltech's complaint primarily revolves around patent infringement under 35 U.S.C. § 271, claiming that Broadcom’s products, particularly in wireless communication and semiconductor devices, infringe upon patents owned by Caltech. The patents in question cover various innovations related to integrated circuit architectures, signal processing, and semiconductor fabrication techniques.

The core allegations include:

  • Direct Infringement: Broadcom's sale and use of products infringing Caltech’s patents.
  • Inducement and Contributory Infringement: Broadcom’s alleged inducement of infringement by encouraging customers to use infringing products.
  • Unfair Competition and Breach of Patent License Agreements: If any licensing agreements existed, potential breaches were also claimed.

Caltech sought injunctive relief, damages, pre-judgment interest, and attorney’s fees, emphasizing the importance of protecting university-held patents to incentivize future research and technological innovation.

Legal Proceedings and Key Developments

The litigation commenced in 2016, with Caltech initiating the suit after unsuccessful licensing negotiations. The case involved intensive discovery, including depositions, technical expert reports, and patent claim construction proceedings, which are common in patent infringement cases.

Claim Construction: Both parties engaged in claim construction, a pivotal step where the court interprets patent claim language. This influences the scope of infringement and is often contested.

Summary Judgment Motions: Broadcom filed motions to dismiss or for summary judgment, arguing, among other points, that the patents were invalid or non-infringing. Caltech countered, emphasizing the validity of the patents and the clear infringement by Broadcom’s products.

Patent Validity Challenges: Broadcom challenged the validity of Caltech’s patents through prior art references and indefiniteness arguments, but courts upheld the patents’ validity based on the robustness of Caltech’s prosecution history.

Trial and Patent Damages: If the case proceeded to trial, the court would evaluate infringement, damages, and any potential willful infringement, which could lead to enhanced damages under 35 U.S.C. § 284.

In this dispute, the litigation notably illustrated the complexities of patent enforcement at the intersection of industry innovation and academic research.

Legal and Industry Significance

This litigation underscores several key trends in patent law and technology commercialization:

  • Academic Patents as Strategic Assets: Universities like Caltech increasingly assert patent rights to maximize the commercial potential of their research, often leading to litigation to defend these rights.
  • Industry Vigilance on Patent Infringement: Tech giants such as Broadcom routinely defend against patent infringement claims to protect market share and technology investments.
  • Patent Validity and Enforcement: Courts consistently uphold the validity of patents when adequately prosecuted, reinforcing the importance of thorough patent prosecution practices.
  • Litigation as a Tool for Licensing Negotiations: Enforcing patents through litigation often positions patentees favorably in licensing negotiations rather than pursuing settlement.

While the final resolution in civil cases like this can extend over multiple years, the case’s importance lies in shaping patent assertion tactics and fostering an environment of legal protections for academic innovations.

Implications for Industry and Patent Strategy

For technology companies, the Caltech v. Broadcom case exemplifies the necessity to:

  • Conduct comprehensive freedom-to-operate analyses prior to product launches.
  • Ensure patent portfolios are robust and defensible against validity challenges.
  • Pursue strategic licensing and litigation to reinforce patent rights.
  • Recognize the increasing role of academic institutions in patent enforcement within the tech industry.

This dispute also provides an educational example of how patent rights originate in research institutions and can be leveraged to influence supply chains, product innovation, and market dynamics.

Conclusion

The litigation between Caltech and Broadcom epitomizes the pivotal role of patents in fostering innovation, protecting intellectual property, and resolving disputes within high-stakes technology sectors. While the ongoing case (as of 2023) highlights procedural and substantive patent issues, it also offers strategic lessons for industry stakeholders to proactively secure and enforce patent rights, especially as academic inventions become central to commercial competitiveness.


Key Takeaways

  • Patent enforcement remains a critical strategic component for both academic institutions and industry leaders.
  • Validity of patents can withstand prior art challenges if thoroughly prosecuted and defensible.
  • Litigation often serves as a catalyst for licensing negotiations, impacting market access and revenue.
  • Companies should maintain comprehensive patent portfolios and conduct rigorous clearance searches.
  • Academic institutions increasingly leverage patent rights to sustain research funding and technological leadership.

FAQs

Q1: What are the primary legal allegations in the Caltech v. Broadcom case?
A1: The case centers on patent infringement, alleging Broadcom products infringe on Caltech’s patents related to semiconductor innovations, with claims including direct infringement, inducement, and contributory infringement.

Q2: How does patent validity play a role in this litigation?
A2: Broadcom challenged the patents’ validity through prior art and legal arguments. The court upheld the patents’ validity, emphasizing the importance of robust prosecution and clear claim language.

Q3: What strategies can companies adopt based on this case?
A3: Companies should perform thorough freedom-to-operate analyses, bolster patent portfolios, and be prepared for litigation or licensing negotiations when patent rights are asserted.

Q4: Why are academic patents significant in the technology industry?
A4: Academic patents often cover foundational innovations, offering universities strategic assets for licensing, commercialization, and enforcement, thereby fostering further research and development.

Q5: What are the broader industry implications of this litigation?
A5: The case exemplifies the importance of patentees asserting rights to safeguard innovations, influencing industry licensing practices, patent litigation tactics, and corporate R&D investments.


Sources:
[1] Court filings and case docket, United States District Court for the Central District of California.
[2] Patent publications and Caltech licensing statements.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.